351 related articles for article (PubMed ID: 20881470)
1. Emerging repair, regeneration, and translational research advances for spinal cord injury.
Kwon BK; Sekhon LH; Fehlings MG
Spine (Phila Pa 1976); 2010 Oct; 35(21 Suppl):S263-70. PubMed ID: 20881470
[TBL] [Abstract][Full Text] [Related]
2. Translating mechanisms of neuroprotection, regeneration, and repair to treatment of spinal cord injury.
Siddiqui AM; Khazaei M; Fehlings MG
Prog Brain Res; 2015; 218():15-54. PubMed ID: 25890131
[TBL] [Abstract][Full Text] [Related]
3. Time is spine: a review of translational advances in spinal cord injury.
Badhiwala JH; Ahuja CS; Fehlings MG
J Neurosurg Spine; 2018 Dec; 30(1):1-18. PubMed ID: 30611186
[TBL] [Abstract][Full Text] [Related]
4. Traumatic Spinal Cord Injury-Repair and Regeneration.
Ahuja CS; Nori S; Tetreault L; Wilson J; Kwon B; Harrop J; Choi D; Fehlings MG
Neurosurgery; 2017 Mar; 80(3S):S9-S22. PubMed ID: 28350947
[TBL] [Abstract][Full Text] [Related]
5. Clinical translation of stem cell based interventions for spinal cord injury - Are we there yet?
Chhabra HS; Sarda K
Adv Drug Deliv Rev; 2017 Oct; 120():41-49. PubMed ID: 28964881
[TBL] [Abstract][Full Text] [Related]
6. Leveraging biomedical informatics for assessing plasticity and repair in primate spinal cord injury.
Nielson JL; Haefeli J; Salegio EA; Liu AW; Guandique CF; Stück ED; Hawbecker S; Moseanko R; Strand SC; Zdunowski S; Brock JH; Roy RR; Rosenzweig ES; Nout-Lomas YS; Courtine G; Havton LA; Steward O; Reggie Edgerton V; Tuszynski MH; Beattie MS; Bresnahan JC; Ferguson AR
Brain Res; 2015 Sep; 1619():124-38. PubMed ID: 25451131
[TBL] [Abstract][Full Text] [Related]
7. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury.
Hawryluk GW; Rowland J; Kwon BK; Fehlings MG
Neurosurg Focus; 2008; 25(5):E14. PubMed ID: 18980474
[TBL] [Abstract][Full Text] [Related]
8. Strategies to promote neural repair and regeneration after spinal cord injury.
Kwon BK; Fisher CG; Dvorak MF; Tetzlaff W
Spine (Phila Pa 1976); 2005 Sep; 30(17 Suppl):S3-13. PubMed ID: 16138063
[TBL] [Abstract][Full Text] [Related]
9. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.
Tator CH; Hashimoto R; Raich A; Norvell D; Fehlings MG; Harrop JS; Guest J; Aarabi B; Grossman RG
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):157-229. PubMed ID: 22985382
[TBL] [Abstract][Full Text] [Related]
10. Opinions on the preclinical evaluation of novel therapies for spinal cord injury: a comparison between researchers and spinal cord-injured individuals.
Kwon BK; Ghag A; Reichl L; Dvorak MF; Illes J; Tetzlaff W
J Neurotrauma; 2012 Sep; 29(14):2367-74. PubMed ID: 22776047
[TBL] [Abstract][Full Text] [Related]
11. Translational research in spinal cord injury: a survey of opinion from the SCI community.
Kwon BK; Hillyer J; Tetzlaff W
J Neurotrauma; 2010 Jan; 27(1):21-33. PubMed ID: 19751098
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological approaches to repair the injured spinal cord.
Baptiste DC; Fehlings MG
J Neurotrauma; 2006; 23(3-4):318-34. PubMed ID: 16629619
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord injuries: how could cell therapy help?
Badner A; Siddiqui AM; Fehlings MG
Expert Opin Biol Ther; 2017 May; 17(5):529-541. PubMed ID: 28306359
[TBL] [Abstract][Full Text] [Related]
14. The translational dialogue in spinal cord injury research.
Curt A
Spinal Cord; 2012 May; 50(5):352-7. PubMed ID: 22064661
[TBL] [Abstract][Full Text] [Related]
15. Spinal cord injury: a systematic review of current treatment options.
Cadotte DW; Fehlings MG
Clin Orthop Relat Res; 2011 Mar; 469(3):732-41. PubMed ID: 21080129
[TBL] [Abstract][Full Text] [Related]
16. Stem cells and spinal cord injury repair.
Karimi-Abdolrezaee S; Eftekharpour E
Adv Exp Med Biol; 2012; 760():53-73. PubMed ID: 23281513
[TBL] [Abstract][Full Text] [Related]
17. Conditioned medium of olfactory ensheathing cells promotes the functional recovery and axonal regeneration after contusive spinal cord injury.
Gu M; Gao Z; Li X; Guo L; Lu T; Li Y; He X
Brain Res; 2017 Jan; 1654(Pt A):43-54. PubMed ID: 27789279
[TBL] [Abstract][Full Text] [Related]
18. Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II.
Nagoshi N; Fehlings MG
Expert Opin Investig Drugs; 2015 May; 24(5):645-58. PubMed ID: 25645889
[TBL] [Abstract][Full Text] [Related]
19. Predicting Recruitment Feasibility for Acute Spinal Cord Injury Clinical Trials in Canada Using National Registry Data.
Thibault-Halman G; Rivers CS; Bailey CS; Tsai EC; Drew B; Noonan VK; Fehlings MG; Dvorak MF; Kuerban D; Kwon BK; Christie SD
J Neurotrauma; 2017 Feb; 34(3):599-606. PubMed ID: 27627704
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic interventions after spinal cord injury.
Thuret S; Moon LD; Gage FH
Nat Rev Neurosci; 2006 Aug; 7(8):628-43. PubMed ID: 16858391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
